University of Colorado Cancer Center

 

University of Colorado Cancer Center
Avatar

KRAS-G12V-Mutant NSCLC: Is There Any Benefit With RAF/MEK Inhibitor Following FAK Inhibitor Defactinib?

By University of Colorado Cancer Center FEATURING Ross Camidge
By University of Colorado Cancer Center FEATURING Ross Camidge
456 views
March 5, 2021
Comments 0
Login to view comments. Click here to Login
Videos
13:58

New

Managing R/R LBCL Patients Treated With Pola-R-CHP in 1L and are CAR…

University of Colorado Cancer Center

M. Kamdar

26:38

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

319 views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

323 views
20:06

Frontline Treatment of ALL: Current Standards and Emergence of CAR-T

University of Colorado Cancer Center

M. Schwartz

66 views
08:05

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing L…

2024 ASCO® Annual Meeting Insights Hub

M. Kamdar

75 views
07:38

EHA 2024 Insights: TRANSCEND NHL 001 Study - Liso-Cel in R/R MCL - A…

Insights from 2024 EHA Annual Meeting

M. Kamdar

52 views
39:44

Understanding Immune Fitness and Age to Improve Breast Cancer Outcom…

University of Colorado Cancer Center

S. Mcallister

16 views
44:36

Type 2 Diabetes Risk With Endocrine Therapies for Breast Cancer

University of Colorado Cancer Center

R. Scalzo

18 views
10:19

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

University of Colorado Cancer Center

T. Flaig

337 views
13:36

Colorectal Surgery for Lynch Syndrome

University of Colorado Cancer Center

J. Vogel

78 views
15:33

Treatment Options for Patients With Lynch Syndrome & CRC

University of Colorado Cancer Center

C. Lieu

309 views
41:30

Lynch Syndrome: The Past, the Present, and the Future

University of Colorado Cancer Center

P. Lynch

225 views
46:03

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

269 views
14:52

Efforts to Understand Metastatic Drivers of Acral Melanoma

University of Colorado Cancer Center

V. Rebecca

16 views
22:23

Delineating the Therapy Resistance Landscape of Acral Melanoma

University of Colorado Cancer Center

V. Rebecca

8 views
07:25

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenance The…

Insights from 2024 SGO Annual Meeting

B. Corr

287 views
11:43

ASH 2023 Insights: "Selection of Bispecific Antibody Therapies or CA…

Insights from 2023 ASH Annual Meeting

M. Kamdar

177 views
07:11

ASH 2023 Insights: "Results From a Ph1 Study of the All-Oral Regimen…

Insights from 2023 ASH Annual Meeting

M. Amaya

157 views
14:59

EGFR Exon 20 Insertion Mutations in NSCLC: Optimal and “Soon to Be O…

University of Colorado Cancer Center

T. Patil

204 views
11:37

Assessment and Decision Tools for Balancing Survival and Quality of …

Insights from 2023 ASCO® Annual Meeting

E. Kessler

94 views
21:12

Current 1L Approaches to ALK and ROS1 NSCLC

University of Colorado Cancer Center

T. Patil

204 views
09:09

ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozanti…

Insights from 2023 ASCO® Annual Meeting

H. Ebrahimi

105 views
05:36

ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Trial -…

Insights from 2023 ASCO® Annual Meeting

T. Flaig

111 views
09:45

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary Refra…

Insights from 2023 ASCO® Annual Meeting

M. Kamdar

635 views
03:26

The BRUIN Study: Pirtobrutinib in Mantle Cell Lymphoma

PrecisCa

M. Kamdar

198 views
07:47

Treatment Approach for Older Patients With Mantle Cell Lymphoma: A D…

PrecisCa

M. Kamdar

226 views
02:52

ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of the A…

Insights from 2023 ASCO® Annual Meeting

M. Amaya

427 views
03:33

Mosunetuzumab in R/R Follicular Lymphoma

PrecisCa

M. Kamdar

198 views
02:53

The POLARIX Trial: Polatuzumab With R-CHP in DLBCL

PrecisCa

M. Kamdar

256 views
06:28

Updates From the ECHELON-1 Trial Utilizing Brentuximab in Hodgkin’s …

PrecisCa

M. Kamdar

99 views
18:33

Sexual & Marital Dysfunction in Women With Gynecologic Cancer

Total Health

S. Guntupalli

34 views
21:35

Management of Advanced NSCLC: IO, Targeted Therapy, and Beyond

Total Health

T. Patil

276 views
22:52

Breast Cancer Genetics, Genomics, and Emerging Diagnostic Tools

Total Health

R. Acharya-Leon

246 views
20:16

Updated NCCN Guidelines for HR+/HER2- mBC: Treatment Options in 1L S…

University of Colorado Cancer Center

V. Borges

1.5K views
19:23

Evolving Paradigms in the Management of Early-Stage NSCLC

University of Colorado Cancer Center

T. Patil

260 views
12:42

Management of Patients With R/R MCL

University of Colorado Cancer Center

M. Kamdar

221 views
40:59

Cancer 'Super-Survivors': ALK+ NSCLC

University of Colorado Cancer Center

R. Camidge

959 views
04:56

Liso-Cel CAR T-Cell Therapy vs. Salvage Chemo Followed by ASCT as 2L…

University of Colorado Cancer Center

M. Kamdar

26 views
08:29

Application and Development of ctDNA in Early Stage CRC

University of Colorado Cancer Center

C. Lieu

129 views
07:12

New Opportunities in Advanced KRAS Mutation-Positive NSCLC: Biomarke…

i3 Health

R. Camidge, B. Sandy

173 views
11:24

Practical Principles of Biomarker Testing in aNSCLC: FDA Approved Th…

University of Colorado Cancer Center

T. Patil

258 views
15:14

Practical Principles of Biomarker Testing in aNSCLC: Overview of Cur…

University of Colorado Cancer Center

T. Patil

311 views
09:54

Targeting mNSCLC: Alectinib & Crizotinib, Chemoimmunotherapy in the …

University of Colorado Cancer Center

T. Patil

210 views
06:46

KRAS-G12V-Mutant NSCLC: Is There Any Benefit With RAF/MEK Inhibitor …

University of Colorado Cancer Center

R. Camidge

456 views
14:33

KRAS-Mutated NSCLC Update: Are We Close to a Highly-Effective Target…

University of Colorado Cancer Center

J. Pacheco

416 views
20:06

How I Treat Lung Cancer in 2020: Major Risk Factors & Death Rates, H…

University of Colorado Cancer Center

T. Patil

895 views
10:45

How I Treat Early NSCLC in 2020: How Critical Is Lymph Node Determin…

University of Colorado Cancer Center

T. Patil

580 views
09:29

mNSCLC Treatment: How Critical Is Molecular Profiling for Targeted T…

University of Colorado Cancer Center

T. Patil

693 views
15:28

ES-SCLC Paradigm Change Following IMpower133 and CASPIAN Trials: Wha…

University of Colorado Cancer Center

J. Pacheco

632 views
25:36

Brigatinib vs Crizotinib in Advanced ALK+ NSCLC: A Glimpse Into the …

University of Colorado Cancer Center

R. Camidge

1.1K views